Medication info

Ranix 150 mg Tablets (Ranitidine Hydrochloride)

Prescription medicationTabletOralExpired
Ingredient · strength
Ranitidine Hydrochloride›168mg / 1 tablet
Manufacturer / importer
Shinil Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 500 tablets/bottle
Approval status
Expired

MFDS item code 199602199 · Notified 1996.12.30

This product's status changed to Expired on 2025.04.01. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of acid-related disorders (e.g., ulcers and esophagitis), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome
Who takes it
Adults · Children
Adult dose
Administer orally as ranitidine 150 mg twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer this drug orally at 150 mg twice daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The same dosage regimen applies to ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and to concomitant therapy for preventing gastric or duodenal ulcers during long-term NSAID treatment. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by NSAID treatment, although the healing period may occasionally be longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer this drug at 150 mg twice daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 150 mg 3 times daily; the dose may be increased as needed. In severe disease, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration of this drug at 150 mg twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer this drug at 150 mg once daily at bedtime. 3. Patients with renal impairment In patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis decreases the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.
Child dose
For patients 12 years of age and older, administer this drug orally at 75 mg twice daily (liquid formulation only). For patients 8 〜 18 years of age, up to 150 mg per dose (2 mg/kg) may be administered twice daily.

Ingredients

Manufacturer
Shinil Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of acid-related disorders (e.g., ulcers and esophagitis), improvement of gastric mucosal lesions, and prevention of Mendelson syndrome

  • Gastric ulcers
  • duodenal ulcers
  • Zollinger-Ellison syndrome
  • gastroesophageal reflux disease
  • Mendelson's syndrome
  • postoperative ulcers
  • ulcers caused by non-steroidal anti-inflammatory drug use
  • gastric mucosal lesions
  • erosion
  • bleeding
  • erythema
  • edema
View approved original text

This medication is used in the treatment of various gastrointestinal diseases such as gastric and duodenal ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease. It is also effective in preventing Mendelson's syndrome before anesthesia and treating ulcers after surgery, as well as those caused by NSAID use. It helps improve gastric mucosal lesions caused by acute exacerbation of acute and chronic gastritis and is also used for the treatment of upper gastrointestinal bleeding, such as peptic bleeding or stress ulcers. Additionally, it alleviates symptoms of excessive stomach acid, heartburn, and belching, thus overall improving patients' gastric health.

How to take

Adult dose

Administer orally as ranitidine 150 mg twice daily, in the morning and at bedtime. 1) Gastric and duodenal ulcers Administer this drug orally at 150 mg twice daily, or 300 mg once daily at bedtime. A higher healing rate may be achieved, particularly in patients with duodenal ulcers, by administering 300 mg twice daily, in the morning and at bedtime. The same dosage regimen applies to ulcers caused by nonsteroidal anti-inflammatory drugs (NSAIDs) and to concomitant therapy for preventing gastric or duodenal ulcers during long-term NSAID treatment. Healing usually occurs within 4 weeks, or within 8 weeks for conditions caused by NSAID treatment, although the healing period may occasionally be longer depending on the patient. For patients with recurrent ulcers who responded well to short-term treatment with this drug, administer 150 mg once daily at bedtime as maintenance therapy. 2) Reflux esophagitis Administer this drug at 150 mg twice daily for 8 weeks, or 300 mg once daily before bedtime. The dose may be increased to 150 mg 4 times daily in patients with severe reflux esophagitis. 3) Zollinger-Ellison syndrome Begin treatment with an initial dose of 150 mg 3 times daily; the dose may be increased as needed. In severe disease, up to 6 g per day may be administered as directed by a physician. 4) In cases of upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or acute gastric mucosal lesions, treatment is usually initiated with an injectable formulation. Once oral administration is possible, switch to oral administration of this drug at 150 mg twice daily. 5) Premedication before anesthesia (prevention of Mendelson syndrome) Administer 150 mg of this drug 2 hours before induction of anesthesia. It is preferable to also administer 150 mg on the evening before surgery. 6) Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Administer this drug at 150 mg once daily at bedtime. 3. Patients with renal impairment In patients with severe renal impairment and creatinine clearance of 50 mL/min or less, administer 150 mg once daily at bedtime. Depending on the patient's condition, the dosing interval may be extended to 12 hours or longer. Hemodialysis decreases the blood concentration of the drug; therefore, adjust the dosing schedule immediately after hemodialysis. Adjust the dose as appropriate according to age and symptoms.

Child dose

For patients 12 years of age and older, administer this drug orally at 75 mg twice daily (liquid formulation only). For patients 8 〜 18 years of age, up to 150 mg per dose (2 mg/kg) may be administered twice daily.

Precautions

This medication should not be used in patients who have had allergic reactions to its components. It should also be avoided in patients who have a history of acute porphyria. Patients with poor kidney function should reduce the dosage or increase the dosing interval, as this medication may remain in the body for a longer period. Patients with impaired liver function should also use with caution. Patients with a history of drug allergies or the elderly should be administered this medication with care. Particular caution is required when taken with non-steroidal anti-inflammatory drugs; the elderly with a history of gastric ulcers require regular check-ups. This medication may conceal symptoms of stomach cancer, so gastric ulcer patients or middle-aged and older patients with indigestion should verify malignancy before taking. Patients with gastric and duodenal ulcers caused by Helicobacter pylori should undergo eradication therapy simultaneously. During treatment with this medication, rare but serious allergic reactions, blood abnormalities, liver function impairment, heart issues, and gastrointestinal symptoms may occur, necessitating immediate consultation with a physician if unusual symptoms arise. If dizziness or drowsiness occurs, avoid driving or operating dangerous machinery. Drug interactions may occur when taken with other medications, so it is essential to inform the physician or pharmacist of any current medications. Women who are pregnant or breastfeeding should use this medication with caution, and it should only be administered when the benefits outweigh the risks. Safety has not been sufficiently established in children, so cautious use is required. The elderly may have impaired kidney function and may need dosage adjustments. This medication reduces stomach acid secretion, potentially promoting bacterial growth in the gastrointestinal tract, so eye examinations may be necessary with long-term use. Keep out of reach of children, and do not transfer to other containers.

Side effects

  • Anaphylactic shock
  • urticaria
  • angioedema
  • rash
  • fever
  • bronchospasm
  • hypotension
  • chest pain
  • agranulocytosis
  • elevated serum creatinine levels
Show 58 more
  • leukopenia
  • thrombocytopenia
  • hypoplastic bone marrow
  • aplastic anemia
  • refractory anemia
  • agranulosis
  • pancytopenia
  • acquired immune hemolytic anemia
  • eosinophilia
  • general malaise
  • weakness
  • subcutaneous and mucosal bleeding
  • fever
  • liver dysfunction
  • jaundice
  • hepatitis
  • bradycardia
  • atrioventricular block
  • tachycardia
  • vasculitis
  • constipation
  • nausea
  • vomiting
  • abdominal distension
  • abdominal pain
  • loss of appetite
  • diarrhea
  • acute pancreatitis
  • dizziness
  • drowsiness
  • convulsions
  • headache
  • heaviness in the head
  • insomnia
  • agitation
  • anxiety
  • confusion
  • depression
  • hallucinations
  • blurred vision
  • involuntary movement disorders
  • consciousness disorder
  • liver hypertrophy muscle spasms
  • gynecomastia
  • excessive milk secretion
  • erectile dysfunction
  • decreased libido
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • skin rash
  • erythema multiforme
  • alopecia
  • glossitis
  • pruritus
  • mucous membrane syndrome
  • toxic epidermal necrolysis
  • acute interstitial nephritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored at room temperature between 1°C and 30°C and kept in a dry place free from moisture. Proper storage helps maintain the effectiveness of the medication.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 500 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.